Chemometec AS 

$60.79
55
+$0.00+0% Tuesday 13:04

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
1.06B
P/E Ratio
0
Dividend Yield
1.79%
Dividend
1.09

Upcoming

Dividends

1.79%Dividend Yield
Oct 25
$1.09
Oct 24
$0.58
Oct 23
$0.85
Oct 20
$0.29
Jan 20
$2.55
10Y Growth
N/A
5Y Growth
29.91%
3Y Growth
N/A
1Y Growth
86.37%

Earnings

10SepExpected
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Next
0.54
0.71
0.88
1.05
Expected EPS
0.842772
Actual EPS
N/A

Financials

37.39%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
73.47MRevenue
27.47MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CHHMF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific offers a wide range of analytical instruments and laboratory equipment, competing in the cell analysis market similar to ChemoMetec.
Danaher
DHR
Mkt Cap151.89B
Danaher Corporation, through its subsidiaries, provides various biotech and life sciences products, including cell imaging and analysis systems that compete with ChemoMetec's offerings.
Bio-Rad Laboratories
BIO
Mkt Cap10.37B
Bio-Rad Laboratories, Inc. produces and supplies systems for the life science research and clinical diagnostics markets, including cell counting and imaging products.
Agilon Health
AGL
Mkt Cap1.55B
Agilent Technologies provides instruments, services, and consumables for laboratories worldwide, including cell analysis technologies that rival ChemoMetec's.
Illumina
ILMN
Mkt Cap32.55B
Illumina, Inc. offers sequencing and array-based solutions for genetic analysis, which competes with ChemoMetec's cell analysis technologies in the genomics and research sectors.
Repligen
RGEN
Mkt Cap9.95B
Repligen Corporation supplies bioprocessing technologies and systems that are used in the production of biological drugs, competing indirectly by offering complementary technologies for cell analysis.
Bio-Techne
TECH
Mkt Cap11.35B
Bio-Techne Corporation develops, manufactures, and sells life sciences reagents, instruments, and services for research, including cell and gene analysis products that compete with ChemoMetec.
Qiagen NV
QGEN
Mkt Cap8.9B
Qiagen N.V. provides sample to insight solutions that transform biological materials into valuable molecular insights, including cell analysis technologies that compete with ChemoMetec's offerings.

About

Headquartered in Allerød, Denmark, and established in 1997, ChemoMetec A/S focuses on the design, production, and worldwide distribution of analytical instruments for cell enumeration and analysis. Their sophisticated solutions are utilized across diverse fields, including cell-based therapeutics, oncology and stem cell research, pharmaceutical development and manufacturing, along with quality assurance for animal semen and beer. The company's product offerings feature a range of NucleoCounter devices, such as the NC-3000 advanced image cytometer, the NC-250 automated cell analyzer, and the consistent NC-202 and NC-200 automated cell counters for viability assessment. Specialized counters include the NucleoCounter SP-100 for automated sperm cell analysis in animal production, the SCC-100 for measuring somatic cells in milk samples, and the YC-100 for total count and viability of yeast cells. Beyond equipment, they also supply vital consumables like cassettes and reagents, various accessories such as software and cables, and offer extensive service and validation plans.
Show more...
CEO
Claus Madsen
Employees
172
Country
Denmark
ISIN
DK0060055861
WKN
000A0MS80

Listings

0 Comments

Share your thoughts

FAQ

What is Chemometec AS stock price today?
The current price of CHHMF is $60.79 USD — it has increased by +0% in the past 24 hours. Watch Chemometec AS stock price performance more closely on the chart.
What is Chemometec AS stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Chemometec AS stocks are traded under the ticker CHHMF.
What is Chemometec AS market cap?
Today Chemometec AS has the market capitalization of 1.06B
When is the next Chemometec AS earnings date?
Chemometec AS is going to release the next earnings report on September 10, 2026.
What were Chemometec AS earnings last quarter?
CHHMF earnings for the last quarter are 0.85 USD per share, whereas the estimation was 1.05 USD resulting in a -19.16% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Chemometec AS revenue for the last year?
Chemometec AS revenue for the last year amounts to 73.47M USD.
What is Chemometec AS net income for the last year?
CHHMF net income for the last year is 27.47M USD.
Does Chemometec AS pay dividends?
Yes, CHHMF dividends are paid annual. The last dividend per share was 1.09 USD. As of today, Dividend Yield (FWD)% is 1.79%.
How many employees does Chemometec AS have?
As of September 05, 2026, the company has 172 employees.
In which sector is Chemometec AS located?
Chemometec AS operates in the Technology sector.
When did Chemometec AS complete a stock split?
Chemometec AS has not had any recent stock splits.
Where is Chemometec AS headquartered?
Chemometec AS is headquartered in Gydevang 43, Denmark.